Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(tert-Butoxycarbonyl)-4-piperidinecarboxylic acid → 4-(3-Benzyl-[1,2,4]oxadiazol-5-yl)-piperidine hydrochloride
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(tert-Butoxycarbonyl)-4-piperidinecarboxylic acid | HCID 392871 | — |
| 반응물 | N'-hydroxy-2-phenylethanimidamide | HCID 2731007 | — |
| 반응물 | 4-{3-[4-(Methylthio)benzyl]-1,2,4-oxadiazol-5-yl}piperidine hydrochloride | HCID 68709132 | — |
| 생성물 | 4-(3-Benzyl-[1,2,4]oxadiazol-5-yl)-piperidine hydrochloride | HCID 68707330 | — |
반응 단계
This was prepared from N′-hydroxy-2-phenylethanimidamide and 1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid using a similar method to that used to prepare 4-{3-[4-(methylthio)benzyl]-1,2,4-oxadiazol-5-yl}piperidine hydrochloride (Method E, Steps 1, 2); NMR: 1.96 (2H, m), 2.15(2H, dd), 3.01(2H, t), 3.24 (2H, dd), 3.40 (1H, m), 4.09 (2H, s), 7.25 (5H, m), 9.31(2H, br s); MS: 244 (MH+).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07615555B2 |
| 출처 데이터셋 | uspto-grants-2009_11 |
| ORD ID | ord-9b70f4ad96894a518c254c6580ec1a88 |
| 출처 메모 | uspto-grants-2009_11 |